Skip to main content
OpenTrials
Completed

NCT Number: NCT00578773

A Phase II Study of an Otic Formulation in Treating Peri-Operative Tube Otorrhea

The purpose of this study is to determine if an otic formulation is safe and effective in treating peri-operative tube otorrhea.

Completed

Looking for future studies?

Notify Me

Key information

Age range

6 month–12 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 2

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • 6 months to 12 years old
  • Diagnosed with recurrent acute otitis media or chronic otitis media with effusion
  • Must be first set of ear tubes.
  • Patient may not have had any other previous otologic-related surgery.
  • Ear tube may not be silver oxide, silver salt, t-type tube or long-shafted tube
  • Patient may not have existing perforation of the eardrum.
  • Patient must not require another surgical procedure other than myringotomy and tube insertion.
  • Patient may not be a menarchal female
  • Diabetic patients are not eligible
  • Patient may not have any disease or condition that would negatively affect the conduct of the study
  • Patient may not require any other systemic antimicrobial therapy during the study.
  • Patient must meet certain medication washouts to be eligible
  • Analgesic use (other than acetaminophen) is not allowed
  • Patient may not be pre-disposed to neurosensory hearing loss
  • Other protocol-defined inclusion criteria may apply

Exclusion criteria

  • Age
  • Other protocol-defined exclusion criteria may apply

Treatment and study plan

Moxidex otic solution

Drug

4 drops into the infected ear(s) twice daily (morning and evening) for 7 days

Moxifloxacin otic solution

Drug

4 drops into the infected ear(s) twice daily (morning and evening) for 7 days

Tympanostomy tubes

Device

Tubes surgically inserted through the ear drum for the treatment of recurrent otitis media in children

Primary outcomes

  1. Time to cessation of otorrhea as recorded by the parent or guardian via a patient diary

    Time frame: From baseline

Secondary outcomes

  1. Clinical cures at each visit

    Time frame: From baseline

  2. Absence of otorrhea at each visit

    Time frame: From baseline

Sponsors and collaborators

Lead sponsor

Alcon Research

Industry

Registry information

Official study title

Safety and Efficacy of a Topical Otic Formulation in the Treatment of Peri-Operative Tube Otorrhea

Important dates

Study start
2007
Primary completion
2009
Study completion
2009
First posted
Dec 21, 2007
Registry last updated
Dec 3, 2012

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.